Financhill
Back

Innovent Biologics Vs. CASI Pharmaceuticals Industry Stock Comparison

Sell
28

IVBIY
Innovent Biologics

Last Price:
19.15
Seasonality Move:
-2.14%
Sell
21

CASI
CASI Pharmaceuticals

Last Price:
3.17
Seasonality Move:
4.53%
Sell
28
Innovent Biologics (IVBIY) is a Sell

Is Innovent Biologics a Buy, Sell or Hold?

  • The current Innovent Biologics [IVBIY] share price is $19.15. The Score for IVBIY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • IVBIY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
21
CASI Pharmaceuticals (CASI) is a Sell

Is CASI Pharmaceuticals a Buy, Sell or Hold?

  • The current CASI Pharmaceuticals [CASI] share price is $3.11. The Score for CASI is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • CASI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IVBIY Stock Price Chart

What is Innovent Biologics's stock price today?

  • The Innovent Biologics share price today is $19.15
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IVBIY is experiencing slight buying pressure.

CASI Stock Price Chart

What is CASI Pharmaceuticals's stock price today?

  • The CASI Pharmaceuticals share price today is $3.11
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CASI is experiencing selling pressure, which indicates risk of future bearish movement.

IVBIY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 0.69 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.81 - 21.55) Sell
Bollinger Bands (100): (20.03 - 22.27) Sell

CASI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 33.37 Sell
Chaikin Money Flow: -44072 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.42 - 5.4) Sell
Bollinger Bands (100): (4.76 - 6.88) Sell

IVBIY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.15 Sell
20-day SMA: 19.72 Sell
50-day SMA: 21.09 Sell
200-day SMA: 20.28 Sell
8-day EMA: 19.2 Sell
20-day EMA: 19.72 Sell
50-day EMA: 20.56 Sell
200-day EMA: 20.17 Sell

CASI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.31 Sell
20-day SMA: 4.1 Sell
50-day SMA: 5.11 Sell
200-day SMA: 4.81 Sell
8-day EMA: 3.38 Sell
20-day EMA: 3.98 Sell
50-day EMA: 4.81 Sell
200-day EMA: 5.05 Sell

Innovent Biologics Earnings Growth & IVBIY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CASI Pharmaceuticals Earnings Growth & CASI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.93 per share, and an increase next year of $0.34 per share.

Innovent Biologics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CASI Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):